UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Y | Z
Number of items: 369.

A

Abeti, R; Abramov, AY; Duchen, MR; (2011) β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain , 134 (6) pp. 1658-1672. 10.1093/brain/awr104.

Abeti, R; Abramov, AY; Duchen, MR; (2011) beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. BRAIN , 134 1658 - 1672. 10.1093/brain/awr104.

Abramov, AY; Duchen, MR; (2011) Measurements of threshold of mitochondrial permeability transition pore opening in intact and permeabilized cells by flash photolysis of caged calcium. Methods Mol Biol , 793 pp. 299-309. 10.1007/978-1-61779-328-8_19.

Abramov, AY; Gegg, M; Grunewald, A; Wood, NW; Klein, C; Schapira, AHV; (2011) Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease. PLOS ONE , 6 (10) , Article e25622. 10.1371/journal.pone.0025622. Green open access
file

Abramov, AY; Ionov, M; Pavlov, E; Duchen, MR; (2011) Membrane cholesterol content plays a key role in the neurotoxicity of beta-amyloid: implications for Alzheimer's disease. AGING CELL , 10 (4) 595 - 603. 10.1111/j.1474-9726.2011.00685.x.

Abramsson, A; Landgren, S; Zetterberg, M; Seibt Palmer, M; Minthon, L; Gustafson, DR; Skoog, I; (2011) No association of LOXL1 gene polymorphisms with Alzheimer's disease. Neuromolecular Med , 13 (2) pp. 160-166. 10.1007/s12017-011-8144-z.

Ahmed, M; Miller, A; Hanna, MG; Greensmith, L; (2011) Investigating the effects of pharmacological up-regulation of the heat shock response on protein degradation pathways in an in-vitro model of sporadic inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Ahmed, Z; Asi, YT; Lees, AJ; Revesz, T; Holton, JL; (2011) Investigating the role of oligodendroglial precursor cells in multiple system atrophy and progressive supranuclear palsy. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 21 - 21). WILEY-BLACKWELL PUBLISHING, INC

Ahmed, Z; Doherty, K; Silveira-Moriyama, L; Bandopadhyay, R; Lashley, T; Mamais, A; Hondhamuni, G; (2011) GLOBULAR GLIAL TAUOPATHIES: AN EMERGING GROUP OF 4-REPEAT TAUOPATHIES PRESENTING WITH MOTOR NEURON DISEASE OR FRONTOTEMPORAL DEMENTIA. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 22 - 22). WILEY-BLACKWELL

Ahmed, Z; Doherty, K; Silveira-Moriyama, L; Bandopadhyay, R; Lashley, T; Newcombe, J; O'sullivan, SS; (2011) Clinicopathological comparison of globular glial tauopathies presenting with motor neuron disease or frontotemporal dementia: An emerging group of 4-repeat tauopathies. In: (pp. S328-S329).

Ahmed, Z; Doherty, KM; Silveira-Moriyama, L; Bandopadhyay, R; Lashley, T; Mamais, A; Hondhamuni, G; (2011) Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. ACTA NEUROPATHOL , 122 (4) 415 - 428. 10.1007/s00401-011-0857-4.

Alarcón, F; Dueñas, G; Lees, A; (2011) Encephalitis lethargica due to Epstein-Barr virus infection. Mov Disord , 26 (11) pp. 2132-2134. 10.1002/mds.23772.

Allen, G.F.G.; (2011) The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency. Doctoral thesis, UCL (University College London). Green open access
file

Altmeppen, HC; Prox, J; Puig, B; Kluth, MA; Bernreuther, C; Thurm, D; Jorissen, E; (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener , 6 36-. 10.1186/1750-1326-6-36.

Anaya, F; Lees, A; de Silva, R; (2011) TAU GENE PROMOTER rs242557 AND ALLELE-SPECIFIC PROTEIN BINDING. TRANSLATIONAL NEUROSCIENCE , 2 (2) pp. 176-205. 10.2478/s13380-011-0021-6.

Andersson, M; Zetterberg, H; Minthon, L; Blennow, K; Londos, E; (2011) The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia. Int J Geriatr Psychiatry , 26 (1) pp. 100-105. 10.1002/gps.2496.

Anzak, A; Tan, HL; Pogosyan, A; Djamshidian, A; Ling, HL; Lees, A; Brown, P; (2011) Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's disease. EUR J NEUROSCI , 34 (1) 124 - 132. 10.1111/j.1460-9568.2011.07735.x.

Ayala, YM; De Conti, L; Avendaño-Vázquez, SE; Dhir, A; Romano, M; D'Ambrogio, A; Tollervey, J; (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J , 30 (2) pp. 277-288. 10.1038/emboj.2010.310.

Aylward, EH; Nopoulos, PC; Ross, CA; Langbehn, DR; Pierson, RK; Mills, JA; Johnson, HJ; (2011) Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry , 82 (4) pp. 405-410. 10.1136/jnnp.2010.208264.

B

Balazs, R; Vernon, J; Hardy, J; (2011) Epigenetic mechanisms in Alzheimer's disease: progress but much to do. NEUROBIOL AGING , 32 (7) 1181 - 1187. 10.1016/j.neurobiolaging.2011.02.024.

Bammens, L; Chávez-Gutiérrez, L; Tolia, A; Zwijsen, A; De Strooper, B; (2011) Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex. J Biol Chem , 286 (14) pp. 12271-12282. 10.1074/jbc.M110.216978.

Bandopadhyay, R; Mamais, A; Lashley, T; Griffiths, C; Goswami, N; Holton, JL; Revesz, T; (2011) The role of 4E-BP1, a putative LRRK2 interactor in the pathology of IPD and in G2019S LRRK2 mutation cases. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 21 - 21). WILEY-BLACKWELL PUBLISHING, INC

Bateman, RJ; Aisen, PS; De Strooper, B; Fox, NC; Lemere, CA; Ringman, JM; Salloway, S; (2011) Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther , 3 (1) 1-. 10.1186/alzrt59. Gold open access

Bayot, A; Santos, R; Camadro, JM; Rustin, P; (2011) Friedreich's ataxia: the vicious circle hypothesis revisited. BMC Med , 9 112-. 10.1186/1741-7015-9-112.

Becker, EBE; Fogel, BL; Rajakulendran, S; Dulneva, A; Hanna, MG; Perlman, SL; Geschwind, DH; (2011) Candidate Screening of the TRPC3 Gene in Cerebellar Ataxia. CEREBELLUM , 10 (2) 296 - 299. 10.1007/s12311-011-0253-6.

Bell, KF; Al-Mubarak, B; Fowler, JH; Baxter, PS; Gupta, K; Tsujita, T; Chowdhry, S; (2011) Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci U S A , 108 (1) E1-E2. 10.1073/pnas.1015229108.

Benilova, I; De Strooper, B; (2011) An overlooked neurotoxic species in Alzheimer's disease. Nat Neurosci , 14 (8) pp. 949-950. 10.1038/nn.2871.

Bjerke, M; Zetterberg, H; Edman, Å; Blennow, K; Wallin, A; Andreasson, U; (2011) Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. J Alzheimers Dis , 27 (3) pp. 665-676. 10.3233/JAD-2011-110566.

Blazek, D; Kohoutek, J; Bartholomeeusen, K; Johansen, E; Hulinkova, P; Luo, Z; Cimermancic, P; (2011) The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev , 25 (20) pp. 2158-2172. 10.1101/gad.16962311.

Blennow, K; Jonsson, M; Andreasen, N; Rosengren, L; Wallin, A; Hellström, PA; Zetterberg, H; (2011) No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons. Acta Neurol Scand , 123 (4) pp. 245-251. 10.1111/j.1600-0404.2010.01408.x.

Brady, S; Squier, W; Hanna, MG; Hilton-Jones, D; Sewry, C; Holton, JL; (2011) Inclusion body myositis: a diagnostic challenge. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Holton, JL; (2011) Inclusion body myositis: A diagnostic challenge. Presented at: UNSPECIFIED.

Bras, JM; Singleton, AB; (2011) Exome sequencing in Parkinson's disease. CLIN GENET , 80 (2) 104 - 109. 10.1111/j.1399-0004.2011.01722.x.

Brelstaff, J; Lashley, T; Holton, JL; Lees, AJ; Rossor, MN; Bandopadhyay, R; Revesz, T; (2011) Transportin1: a marker of FTLD-FUS. ACTA NEUROPATHOL , 122 (5) 591 - 600. 10.1007/s00401-011-0863-6.

Brodaty, H; Breteler, MM; Dekosky, ST; Dorenlot, P; Fratiglioni, L; Hock, C; Kenigsberg, PA; (2011) The world of dementia beyond 2020. J Am Geriatr Soc , 59 (5) pp. 923-927. 10.1111/j.1532-5415.2011.03365.x.

Brooks, JA; Houlden, H; Melchers, A; Islam, AJ; Ding, J; Li, A; Paudel, R; (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiology of Aging , 32 (3) 10.1016/j.neurobiolaging.2009.11.020.

Brooks, JA; Houlden, H; Melchers, A; Islam, AJ; Ding, JH; Li, A; Paudel, R; (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. NEUROBIOL AGING , 32 (3) , Article 548.e5. 10.1016/j.neurobiolaging.2009.11.020.

Brys, M; Glodzik, L; Mosconi, L; Switalski, R; De Santi, S; Pirraglia, E; Rich, K; (2011) Quantitative structural MRI and CSF biomarkers in early diagnosis of Alzheimer's disease. Advances in Alzheimer's Disease , 2 pp. 141-152. 10.3233/978-1-60750-793-2-141.

Bugeon, L; Taylor, HB; Progatzky, F; Lin, MI; Ellis, CD; Welsh, N; Smith, E; (2011) The NOTCH pathway contributes to cell fate decision in myelopoiesis. Haematologica , 96 (12) pp. 1753-1760. 10.3324/haematol.2011.044115.

Bulteau, AL; Bayot, A; (2011) Mitochondrial proteases and cancer. Biochim Biophys Acta , 1807 (6) pp. 595-601. 10.1016/j.bbabio.2010.12.011.

Burge, J; Hanna, MG; (2011) Muscle Channelopathies. pp. 96-102. 10.1002/9781119973331.ch13.

Burge, J; Horga, A; Griggs, RC; Hanna, MG; HYP HOP Investigators, ; (2011) Double-blind, placebo-controlled, parallel group, phase Ill study comparing dichlorphenamide vs. placebo for the treatment of periodic paralysis (HYP HOP trial). In: NEUROMUSCULAR DISORDERS. (pp. S13 - S13). PERGAMON-ELSEVIER SCIENCE LTD

C

Camargos, ST; Gurgel-Giannetti, J; Lees, A; Hardy, J; Singleton, A; Cardoso, F; (2011) Low prevalence of PANK2 mutations in Brazilian patients with early onset generalised dystonia and basal ganglia abnormalities on MRI. J Neurol Neurosurg Psychiatry , 82 (9) pp. 1059-1060. 10.1136/jnnp.2009.200808.

Carlozzi, NE; Stout, JC; Mills, JA; Duff, K; Beglinger, LJ; Aylward, EH; Whitlock, KB; (2011) Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. Clin Neuropsychol , 25 (5) pp. 757-777. 10.1080/13854046.2011.577811.

Carvajal-Carmona, LG; Cazier, JB; Jones, AM; Howarth, K; Broderick, P; Pittman, A; Dobbins, S; (2011) Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet , 20 (14) pp. 2879-2888. 10.1093/hmg/ddr190.

Carvalho, OP; Thornton, GK; Hertecant, J; Houlden, H; Nicholas, AK; Cox, JJ; Rielly, M; (2011) A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J MED GENET , 48 (2) 131 - 135. 10.1136/jmg.2010.081455.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Chalbot, S; Zetterberg, H; Blennow, K; Fladby, T; Andreasen, N; Grundke-Iqbal, I; Iqbal, K; (2011) Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease. J Alzheimers Dis , 25 (3) pp. 505-515. 10.3233/JAD-2011-101959.

Chibnik, LB; Shulman, JM; Leurgans, SE; Schneider, JA; Wilson, RS; Tran, D; Aubin, C; (2011) CR1 Is Associated with Amyloid Plaque Burden and Age-Related Cognitive Decline. ANN NEUROL , 69 (3) 560 - 569. 10.1002/ana.22277.

Chong, SA; Benilova, I; Shaban, H; De Strooper, B; Devijver, H; Moechars, D; Eberle, W; (2011) Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study. Neurobiol Dis , 44 (3) pp. 284-291. 10.1016/j.nbd.2011.07.006.

Chung, HY; Machado, P; van der Heijde, D; D'Agostino, MA; Dougados, M; (2011) HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis , 70 (11) pp. 1930-1936. 10.1136/ard.2011.152975.

Ciammola, A; Sassone, J; Poletti, B; Mencacci, N; Benti, R; Silani, V; (2011) Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease. Case Reports in Neurological Medicine , 2011 pp. 1-3. 10.1155/2011/696953. Gold open access

Ciammola, A; Sassone, J; Sciacco, M; Mencacci, NE; Ripolone, M; Bizzi, C; Colciago, C; (2011) Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease. Movement Disorders , 26 (1) pp. 130-137. 10.1002/mds.23258.

Claret, M; Smith, MA; Knauf, C; Al-Qassab, H; Woods, A; Heslegrave, A; Piipari, K; (2011) Deletion of Lkb1 in Pro-Opiomelanocortin Neurons Impairs Peripheral Glucose Homeostasis in Mice. DIABETES , 60 (3) 735 - 745. 10.2337/db10-1055.

Cleeter, M; Houlden, H; Simons, P; Al-Shawi, R; Stevanin, G; Durr, A; Hsuan, J; (2011) Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia. AMYOTROPH LATERAL SC , 12 (2) 148 - 149. 10.3109/17482968.2010.543689.

Compta, Y; Parkkinen, L; O'Sullivan, SS; Vandrovcova, J; Holton, JL; Collins, C; Lashley, T; (2011) Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? BRAIN , 134 1493 - 1505. 10.1093/brain/awr031.

Connick, P; Kolappan, M; Patani, R; Scott, MA; Crawley, C; He, XL; Richardson, K; (2011) The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. TRIALS , 12 , Article 62. 10.1186/1745-6215-12-62. Gold open access

Connick, P; Patani, R; Chandran, S; (2011) Stem cells as a resource for regenerative neurology. Pract Neurol , 11 (1) pp. 29-36. 10.1136/jnnp.2010.235184.

Constantinescu, R; Holmberg, B; Rosengren, L; Corneliusson, O; Johnels, B; Zetterberg, H; (2011) Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease. Acta Neurol Scand , 124 (3) pp. 206-210. 10.1111/j.1600-0404.2010.01451.x.

Constantinescu, R; Romer, M; Zetterberg, H; Rosengren, L; Kieburtz, K; (2011) Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease. Parkinsonism Relat Disord , 17 (9) pp. 714-715. 10.1016/j.parkreldis.2011.06.010.

Constantinescu, R; Zetterberg, H; (2011) Urate as a marker of development and progression in Parkinson's disease. Drugs Today (Barc) , 47 (5) pp. 369-380. 10.1358/dot.2011.47.5.1591834.

Crehan, H; Pocock, JM; Hardy, J; (2011) THE ROLE OF MICROGLIAL COMPLEMENT RECEPTOR 1 (CR1) IN ALZHEIMER'S DISEASE. In: GLIA. (pp. S135 - S135). WILEY-BLACKWELL

D

Dahlgren, A; Wargelius, HL; Berglund, KJ; Fahlke, C; Blennow, K; Zetterberg, H; Oreland, L; (2011) Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol Alcohol , 46 (5) pp. 509-513. 10.1093/alcalc/agr045.

Deas, E; Plun-Favreau, H; Gandhi, S; Desmond, H; Kjaer, S; Loh, SHY; Renton, AEM; (2011) PINK1 cleavage at position A103 by the mitochondrial protease PARL. Human Molecular Genetics , 20 (5) pp. 867-879. 10.1093/hmg/ddq526. Green open access
file

Deas, E; Wood, NW; Plun-Favreau, H; (2011) Mitophagy and Parkinson's disease: The PINK1-parkin link. BBA-MOL CELL RES , 1813 (4) 623 - 633. 10.1016/j.bbamcr.2010.08.007.

Deriziotis, P; Andre, R; Smith, DM; Goold, R; Kinghorn, KJ; Kristiansen, M; Nathan, JA; (2011) Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J , 30 (15) 3065 - 3077. 10.1038/emboj.2011.224.

Deriziotis, P; Andre, R; Smith, DM; Goold, R; Kinghorn, KJ; Kristiansen, M; Nathan, JA; (2011) Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J , 30 (15) pp. 3065-3077. 10.1038/emboj.2011.224.

Devine, MJ; Gwinn, K; Singleton, A; Hardy, J; (2011) Parkinson's Disease and alpha-Synuclein Expression. MOVEMENT DISORD , 26 (12) 2160 - 2168. 10.1002/mds.23948.

Devine, MJ; Kaganovich, A; Ryten, M; Mamais, A; Trabzuni, D; Manzoni, C; McGoldrick, P; (2011) Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue. PLOS ONE , 6 (7) , Article e22489. 10.1371/journal.pone.0022489. Green open access
file

Devine, MJ; Plun-Favreau, H; Wood, NW; (2011) Parkinson's disease and cancer: two wars, one front. NAT REV CANCER , 11 (11) 812 - +. 10.1038/nrc3150.

Devine, MJ; Ryten, M; Vodicka, P; Thomson, AJ; Burdon, T; Houlden, H; Cavaleri, F; (2011) Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. NAT COMMUN , 2 , Article 440. 10.1038/ncomms1453. Gold open access

Dihanich, S; Manzoni, C; (2011) LRRK2: A Problem Lurking in Vesicle Trafficking? J NEUROSCI , 31 (27) 9787 - 9788. 10.1523/JNEUROSCI.1976-11.2011. Gold open access

Djamshidian, A; Averbeck, BB; Lees, AJ; O'Sullivan, SS; (2011) Clinical aspects of impulsive compulsive behaviours in Parkinson's disease. J Neurol Sci , 310 (1-2) pp. 183-188. 10.1016/j.jns.2011.07.031.

Djamshidian, A; Cardoso, F; Grosset, D; Bowden-Jones, H; Lees, AJ; (2011) Pathological Gambling in Parkinson's Disease-A Review of the Literature. MOVEMENT DISORD , 26 (11) 1976 - 1984. 10.1002/mds.23821.

Djamshidian, A; O apos Sullivan, SS; Doherty, K; Lees, AJ; Averbeck, BB; (2011) Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. Neuropsychologia , 49 (1) pp. 103-107. 10.1016/j.neuropsychologia.2010.10.012.

Djamshidian, A; O'Sullivan, SS; Doherty, K; Lees, AJ; Averbeck, BB; (2011) Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. NEUROPSYCHOLOGIA , 49 (1) 103 - 107. 10.1016/j.neuropsychologia.2010.10.012.

Djamshidian, A; O'Sullivan, SS; Lees, A; Averbeck, BB; (2011) Stroop test performance in impulsive and non impulsive patients with Parkinson's disease. PARKINSONISM RELAT D , 17 (3) 212 - 214. 10.1016/j.parkreldis.2010.12.014.

Djamshidian, A; O'Sullivan, SS; Papadopoulos, A; Bassett, P; Shaw, K; Averbeck, BB; Lees, A; (2011) Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour. J NEUROL NEUROSUR PS , 82 (10) 1107 - 1111. 10.1136/jnnp.2011.245746. Gold open access

Djamshidian, A; O'Sullivan, SS; Wittmann, BC; Lees, AJ; Averbeck, BB; (2011) Novelty seeking behaviour in Parkinson's disease. Neuropsychologia

Djamshidian, A; O'Sullivan, SS; Wittmann, BC; Lees, AJ; Averbeck, BB; (2011) Novelty seeking behaviour in Parkinson's disease. Neuropsychologia , 49 (9) pp. 2483-2488. 10.1016/j.neuropsychologia.2011.04.026.

Djamshidian, A; O'Sullivan, SS; Wittmann, BC; Lees, AJ; Averbeck, BB; (2011) Novelty seeking behaviour in Parkinson's disease. NEUROPSYCHOLOGIA , 49 (9) 2483 - 2488. 10.1016/j.neuropsychologia.2011.04.026.

Djamshidian, A; O'sullivan, SS; Papadopoulos, A; Bassett, P; Shaw, K; Averbeck, BB; Lees, AJ; (2011) Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour. In: MOVEMENT DISORDERS. (pp. S101 - S101).

Doherty, KM; Silveira-Moriyama, L; Davagnanam, I; Molloy, S; Lees, AJ; (2011) Spinal changes underlying postural deformity in Parkinson's disease. Presented at: UNSPECIFIED.

Domijan, AM; Abramov, AY; (2011) Fumonisin B-1 inhibits mitochondrial respiration and deregulates calcium homeostasis-Implication to mechanism of cell toxicity. INT J BIOCHEM CELL B , 43 (6) 897 - 904. 10.1016/j.biocel.2011.03.003.

Duchen, MR; Heath, K; Baruch, NB; Hanna, MG; Muntoni, F; (2011) Dysregulation of calcium and mitochondrial function as potential therapeutic targets in muscle disease. In: NEUROMUSCULAR DISORDERS. (pp. S1 - S2). PERGAMON-ELSEVIER SCIENCE LTD

Dunn, L.M.; (2011) Characterisation of leucine-rich repeat kinase-2 regulation and kinase function. Doctoral thesis, UCL (University College London). Green open access
file

Durran, S; Matthews, E; Rayan, DLR; Sud, R; Polke, J; Haworth, A; Holton, JL; (2011) Genetic heterogeneity and mechanisms of phenotypic variability in human skeletal muscle channelopathies - a new S4 mutation not associated with HypoPP. In: NEUROMUSCULAR DISORDERS. (pp. S13 - S13). PERGAMON-ELSEVIER SCIENCE LTD

E

Edsbagge, M; Starck, G; Zetterberg, H; Ziegelitz, D; Wikkelso, C; (2011) Spinal cerebrospinal fluid volume in healthy elderly individuals. Clin Anat , 24 (6) pp. 733-740. 10.1002/ca.21153.

Elias, E; Benrick, A; Behre, CJ; Ekman, R; Zetterberg, H; Stenlöf, K; Wallenius, V; (2011) Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans. J Neuroendocrinol , 23 (6) pp. 501-507. 10.1111/j.1365-2826.2011.02128.x.

Evans, DM; Spencer, CCA; Pointon, JJ; Su, Z; Harvey, D; Kochan, G; Opperman, U; (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. NAT GENET , 43 (8) 761 - U67. 10.1038/ng.873.

F

Fabbrini, G; Merello, M; Evans, AH; Lees, AJ; Holton, J; Williams, DR; (2011) Progressive Parkinsonism, Oculomotor Abnormalities and Autonomic Dysfunction: Clinicopathological Case. MOVEMENT DISORD , 26 (3) 424 - 429. 10.1002/mds.23302.

Fabbrini, G; Merello, M; Evans, AH; Lees, AJ; Holton, J; Williams, DR; (2011) Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case. Movement Disorders , 26 (3) pp. 424-429. 10.1002/mds.23302.

Farfel-Becker, T; Vitner, EB; Pressey, SNR; Eilam, R; Cooper, JD; Futerman, AH; (2011) Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. HUM MOL GENET , 20 (7) 1375 - 1386. 10.1093/hmg/ddr019.

Fawcett, K; Murphy, SM; Polke, J; Reilly, MM; Houlden, H; (2011) TRPV4 mutations and functional characterisation in a cohort of patients with hereditary neuropathy. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16). PERGAMON-ELSEVIER SCIENCE LTD

Fawcett, K; Murphy, SM; Reilly, MM; Houlden, H; (2011) TRPV4 MUTATIONS AND FUNCTIONAL CHARACTERISATION IN A COHORT OF PATIENTS WITH HEREDITARY NEUROPATHY. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S36 - S36). WILEY-BLACKWELL

Ferrari, R; Hardy, J; Momeni, P; (2011) Frontotemporal dementia: from Mendelian genetics towards genome wide association studies. J Mol Neurosci , 45 (3) pp. 500-515. 10.1007/s12031-011-9635-y.

Fletcher, E.V.; (2011) Alternative splicing in SCN1A: biophysical consequences for NaV1.1 channels. Doctoral thesis, UCL (University College London). Green open access
file

Fonseca, JE; Bernardes, M; Canhão, H; Santos, MJ; Quintal, A; Malcata, A; Neto, A; (2011) Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update. Acta Reumatol Port , 36 (4) pp. 385-388.

Forrest, KML; Al-Sarraj, S; Sewry, C; Buk, S; Tan, SV; Pitt, M; Durward, A; (2011) Infantile onset myofibrillar myopathy due to recessive CRYAB mutations. NEUROMUSCULAR DISORD , 21 (1) 37 - 40. 10.1016/j.nmd.2010.11.003.

Fratter, C; Raman, P; Alston, C; Blakely, EL; Craig, K; Smith, C; Evans, J; (2011) Dominant and recessive RRM2B mutations cause familial PEO and multiple mtDNA deletions in muscle. In: NEUROMUSCULAR DISORDERS. (pp. S23 - S23). PERGAMON-ELSEVIER SCIENCE LTD

Fratter, C; Raman, P; Alston, CL; Blakely, EL; Craig, K; Smith, C; Evans, J; (2011) RRM2B MUTATIONS ARE FREQUENT IN FAMILIAL PEO WITH MULTIPLE mtDNA DELETIONS. NEUROLOGY , 76 (23) 2032 - 2034. 10.1212/WNL.0b013e31821e558b.

Fratter, C; Raman, P; Alston, CL; Blakely, EL; Craig, K; Smith, C; Evans, J; (2011) Dominant and recessive RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. In: JOURNAL OF MEDICAL GENETICS. (pp. S69 - S69). B M J PUBLISHING GROUP

G

Gallagher, DA; Parkkinen, L; O'Sullivan, SS; Spratt, A; Shah, A; Davey, CC; Bremner, FD; (2011) Testing an aetiological model of visual hallucinations in Parkinson's disease. BRAIN , 134 3299 - 3309. 10.1093/brain/awr225.

Gasser, T; Hardy, J; Mizuno, Y; (2011) Milestones in PD Genetics. MOVEMENT DISORD , 26 (6) 1042 - 1048. 10.1002/mds.23637.

Glodzik, L; de Santi, S; Tsui, WH; Mosconi, L; Zinkowski, R; Pirraglia, E; Wang, HY; (2011) Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol Aging , 32 (12) pp. 2131-2141. 10.1016/j.neurobiolaging.2009.12.026.

Glomski, K; Monette, S; Manova, K; De Strooper, B; Saftig, P; Blobel, CP; (2011) Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood , 118 (4) pp. 1163-1174. 10.1182/blood-2011-04-348557.

Granata, A; Koo, SJ; Haucke, V; Schiavo, G; Warner, TT; (2011) CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process. EMBO J , 30 (1) 181 - 193. 10.1038/emboj.2010.285. Gold open access

Gray, A; Malik, B; Montague, K; Dick, J; Hanna, MG; Greensmith, L; (2011) Investigating pathophysiology and therapeutic strategies in a mouse model of spinal and bulbar muscular atrophy (SBMA). In: NEUROMUSCULAR DISORDERS. (pp. S10 - S10). PERGAMON-ELSEVIER SCIENCE LTD

Grosset, DG; Cardoso, F; Lees, A; (2011) Dopamine agonists vs levodopa in impulse control disorders. Arch Neurol , 68 (4) pp. 544-545. 10.1001/archneurol.2011.41.

Guerreiro, RJ; Hardy, J; (2011) Alzheimer's disease genetics: lessons to improve disease modelling. BIOCHEM SOC T , 39 910 - 916. 10.1042/BST0390910.

Gwinn, K; Devine, MJ; Jin, LW; Johnson, J; Bird, T; Muenter, M; Waters, C; (2011) Clinical Features, with Video Documentation, of the Original Familial Lewy Body Parkinsonism Caused By alpha-Synuclein Triplication (Iowa Kindred). MOVEMENT DISORD , 26 (11) 2134 - 2136. 10.1002/mds.23776.

H

Hadavi, S; Noyce, AJ; Leslie, RD; Giovannoni, G; (2011) Stiff person syndrome. Pract Neurol , 11 (5) pp. 272-282. 10.1136/practneurol-2011-000071.

Halim, A; Brinkmalm, G; Rüetschi, U; Westman-Brinkmalm, A; Portelius, E; Zetterberg, H; Blennow, K; (2011) Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A , 108 (29) pp. 11848-11853. 10.1073/pnas.1102664108.

Halliday, G; Lees, A; Stern, M; (2011) Milestones in Parkinson's disease--clinical and pathologic features. Mov Disord , 26 (6) pp. 1015-1021. 10.1002/mds.23669.

Halliday, GM; Holton, JL; Revesz, T; Dickson, DW; (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. ACTA NEUROPATHOL , 122 (2) 187 - 204. 10.1007/s00401-011-0852-9.

Hardy, J; (2011) Read all about it! NEW SCI , 211 (2822) 22 - 23.

Hardy, J; Guerreiro, R; (2011) A new way APP mismetabolism can lead to Alzheimer's disease. EMBO MOL MED , 3 (5) 247 - 248. 10.1002/emmm.201100139. Gold open access

Hardy, J; Guerreiro, R; Lovestone, S; (2011) Clusterin as an Alzheimer biomarker. Arch Neurol , 68 (11) pp. 1459-1460. 10.1001/archneurol.2011.1000.

Hardy, J; Guerreiro, R; Wray, S; Ferrari, R; Momeni, P; (2011) The Genetics of Alzheimer's Disease and Other Tauopathies. J ALZHEIMERS DIS , 23 S33 - S39.

Hardy, J; Low, NC; (2011) Genes and Environment in Psychiatry Winner's Curse or Cure? ARCH GEN PSYCHIAT , 68 (5) 455 - 456.

Hardy, J; Thompson, AJ; (2011) Dissecting the Familial Risk of Multiple Sclerosis. ANN NEUROL , 69 (1) 11 - 12. 10.1002/ana.22353.

Haworth, A; Bertram, L; Carrera, P; Elson, JL; Braastad, CD; Cox, DW; Cruts, M; (2011) Call for participation in the neurogenetics consortium within the Human Variome Project. NEUROGENETICS , 12 (3) 169 - 173. 10.1007/s10048-011-0287-4.

Hazlewood, G; Aletaha, D; Carmona, L; Landewé, RB; van der Heijde, DM; Bijlsma, JW; Bykerk, VP; (2011) Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. J Rheumatol Suppl , 87 pp. 54-58. 10.3899/jrheum.101076.

Hesse, C; Johansson, I; Mattsson, N; Bremell, D; Andreasson, U; Halim, A; Anckarsäter, R; (2011) The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis. Biochem Biophys Res Commun , 412 (3) pp. 494-499. 10.1016/j.bbrc.2011.07.129.

Hoglinger, GU; Melhem, NM; Dickson, DW; Sleiman, PMA; Wang, LS; Klei, L; Rademakers, R; (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. NAT GENET , 43 (7) 699 - U125. 10.1038/ng.859.

Hollingworth, P; Harold, D; Sims, R; Gerrish, A; Lambert, JC; Carrasquillo, MM; Abraham, R; (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. NAT GENET , 43 (5) 429 - +. 10.1038/ng.803.

Holmes, MV; Newcombe, P; Hubacek, JA; Sofat, R; Ricketts, SL; Cooper, J; Breteler, MMB; (2011) Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. LANCET , 378 (9791) 584 - 594. 10.1016/S0140-6736(11)60872-6. Gold open access

Holton, JL; Lees, AJ; Revesz, T; (2011) Multiple System Atrophy. pp. 242-252. 10.1002/9781444341256.ch24.

Hutton, EJ; Carty, L; Laurá, M; Houlden, H; Lunn, MP; Brandner, S; Mirsky, R; (2011) c-Jun expression in human neuropathies: a pilot study. J Peripher Nerv Syst , 16 (4) pp. 295-303. 10.1111/j.1529-8027.2011.00360.x.

I

Innes, A; Kalmar, B; Houlden, H; Reilly, MM; Greensmith, L; (2011) Characterisation of novel mutations within heat shock protein 27 causing motor axonopathies. In: NEUROMUSCULAR DISORDERS. (pp. S3 - S3). PERGAMON-ELSEVIER SCIENCE LTD

Ionov, M; Burchell, V; Klajnert, B; Bryszewska, M; Abramov, AY; (2011) MECHANISM OF NEUROPROTECTION OF MELATONIN AGAINST BETA-AMYLOID NEUROTOXICITY. NEUROSCIENCE , 180 229 - 237. 10.1016/j.neuroscience.2011.02.045.

J

Jacobi, H; Bauer, P; Giunti, P; Labrum, R; Sweeney, MG; Charles, P; Duerr, A; (2011) The natural history of spinocerebellar ataxia type 1, 2, 3 and 6: A 2-year follow-up study. In: (pp. S5-S5).

Jacobi, H; Bauer, P; Giunti, P; Labrum, R; Sweeney, MG; Charles, P; Durr, A; (2011) The natural history of spinocerebellar ataxia type 1, 2, 3, and 6 A 2-year follow-up study. NEUROLOGY , 77 (11) 1035 - 1041.

Jaeger, I; Arber, C; Risner-Janiczek, JR; Kuechler, J; Pritzsche, D; Chen, IC; Naveenan, T; (2011) Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development , 138 (20) pp. 4363-4374. 10.1242/dev.066746.

Janiczek, RL; Gambarota, G; Sinclair, CDJ; Yousry, TA; Thornton, JS; Golay, X; Newbould, RD; (2011) Simultaneous T-2 and Lipid Quantitation Using IDEAL-CPMG. MAGN RESON MED , 66 (5) 1293 - 1302. 10.1002/mrm.22916.

Johansson, P; Johansson, JO; Labrie, F; Mattsson, N; Hansson, O; Blennow, K; Zetterberg, H; (2011) Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women. Clin Endocrinol (Oxf) , 75 (3) pp. 301-308. 10.1111/j.1365-2265.2011.04082.x.

Johansson, P; Mattsson, N; Hansson, O; Wallin, A; Johansson, JO; Andreasson, U; Zetterberg, H; (2011) Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population. J Alzheimers Dis , 24 (3) pp. 537-546. 10.3233/JAD-2011-101878.

Jones, L; Holmans, PA; Hamshere, ML; Harold, D; Moskvina, V; Ivanov, D; Pocklington, A; (2011) Correction: genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One , 6 (2) , Article e13950. 10.1371/journal.pone.0013950. Green open access
file

K

Kalmar, B; Innes, A; Rossor, AM; Houlden, H; Schiavo, G; Reilly, MM; Greensmith, L; (2011) ASSESSMENT OF FUNCTIONAL IMPAIRMENTS IN CELLULAR MODELS OF MUTANT HSPB1 INDUCED NEUROPATHIES. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S62 - S63). WILEY-BLACKWELL

Karran, E; Mercken, M; De Strooper, B; (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov , 10 (9) pp. 698-712. 10.1038/nrd3505.

Kearney, SJ; Yip, H; Lees, AJ; Revesz, T; Silveira-Moriyama, L; (2011) Parkinsonism without pathological explanation. Presented at: UNSPECIFIED.

Kinghorn, KJ; (2011) Pathological looping in the synucleinopathies: investigating the link between Parkinson's disease and Gaucher disease. Dis Model Mech , 4 (6) pp. 713-715. 10.1242/dmm.008615. Gold open access

Koepke, J; Haag, C; Feldbrügge, M; Kaffarnik, F; Zarnack, K; Luscombe, NM; König, J; (2011) The RNA-binding protein Rrm4 is essential for efficient secretion of endochitinase Cts1. Molecular and Cellular Proteomics , 10 (12) 10.1074/mcp.M111.011213.

Koepke, J; Kaffarnik, F; Haag, C; Zarnack, K; Luscombe, NM; König, J; Ule, J; (2011) The RNA-binding protein Rrm4 is essential for efficient secretion of endochitinase Cts1. Mol Cell Proteomics , 10 (12) M111.011213-. 10.1074/mcp.M111.011213.

Koevoets, R; Machado, P; Bombardier, C; van der Heijde, DM; (2011) The value of conventional radiographs in undifferentiated arthritis: a systematic review. J Rheumatol Suppl , 87 pp. 26-30. 10.3899/jrheum.101071.

Kojovic, M; Sheerin, UM; Wood, N; Houlden, H; Hardy, J; Bhatia, KP; (2011) Young onset parkinsonism due to alpha synuclein gene multiplication in a consanguineous family - A case report. In: MOVEMENT DISORDERS. (pp. S310 - S311).

Konig, J; Zarnack, K; Rot, G; Curk, T; Kayikci, M; Zupan, B; Turner, DJ; (2011) iCLIP--transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. Journal of visualized experiments : JoVE (50)

Konig, J; Zarnack, K; Rot, G; Curk, T; Kayikci, M; Zupan, B; Turner, DJ; (2011) iCLIP--transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. J Vis Exp (50) 10.3791/2638.

Kovac, S; Domijan, A; Walker, MC; Abramov, AY; (2011) PROLONGED SEIZURE ACTIVITY IMPAIRS MITOCHONDRIAL BIOENERGETICS AND INDUCES CELL DEATH. In: EPILEPSIA. (pp. 85 - 85). WILEY-BLACKWELL

Kovac, S; Domijan, AM; Walker, MC; Abramov, AY; (2011) ROLE OF MITOCHONDRIAL FUNCTION IN SEIZURE-INDUCED NEURONAL CELL DEATH. In: EPILEPSIA. (pp. 45 - 45). WILEY-BLACKWELL

Kruer, MC; Steiner, RD; Merkens, M; Blasco, PA; Phelps, R; Fan, GA; Houlden, H; (2011) Phenotypic Characterization and Autozygosity Mapping of a Novel Locus for Complicated Hereditary Spastic Paraplegia. In: NEUROLOGY. (pp. A89 - A89). LIPPINCOTT WILLIAMS & WILKINS

Kuo, LT; Tsai, SY; Groves, MJ; An, SF; Scaravilli, F; (2011) Gene Expression Profile in Rat Dorsal Root Ganglion Following Sciatic Nerve Injury and Systemic Neurotrophin-3 Administration. J MOL NEUROSCI , 43 (3) 503 - 515. 10.1007/s12031-010-9473-3.

König, J; Zarnack, K; Luscombe, NM; Ule, J; (2011) Protein-RNA interactions: new genomic technologies and perspectives. Nat Rev Genet , 13 (2) pp. 77-83. 10.1038/nrg3141.

L

Landgren, S; Berglund, K; Jerlhag, E; Fahlke, C; Balldin, J; Berggren, U; Zetterberg, H; (2011) Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study. Neuropsychobiology , 64 (1) pp. 38-46. 10.1159/000324992.

Landgren, S; Engel, JA; Hyytiä, P; Zetterberg, H; Blennow, K; Jerlhag, E; (2011) Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav Brain Res , 221 (1) pp. 182-188. 10.1016/j.bbr.2011.03.003.

Lashley, T; Holton, JL; Revesz, T; (2011) TDP-43 pathology may occur in the BRI2 gene-related dementias. ACTA NEUROPATHOL , 121 (4) 559 - 560. 10.1007/s00401-011-0811-5.

Lashley, T; Rohrer, JD; Bandopadhyay, R; Fry, C; Ahmed, Z; Isaacs, AM; Brelstaff, JH; (2011) A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. BRAIN , 134 2548 - 2564. 10.1093/brain/awr160.

Laura, M; Eichler, FS; Hornemann, T; Polke, J; Davis, M; Bull, K; Houlden, H; (2011) HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1: CORRELATION OF SEVERITY AND PLASMA ATYPICAL DEOXY-SPHYNGOID BASES. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S72 - S73). WILEY-BLACKWELL

Lautner, R; Mattsson, N; Schöll, M; Augutis, K; Blennow, K; Olsson, B; Zetterberg, H; (2011) Biomarkers for microglial activation in Alzheimer's disease. Int J Alzheimers Dis , 2011 939426-. 10.4061/2011/939426.

Lees, A; (2011) The Hurricane Port. Mainstream Digital

Lees, AJ; (2011) CAN THERAPY MODIFY NATURAL EVOLUTION OF PARKINSON'S DISEASE? - CONTRA. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 17 - 17).

Lees, AJ; (2011) THE NOSOLOGY OF PARKINSON'S DISEASE. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 638 - 638).

Lindgren, HS; Rylander, D; Iderberg, H; Andersson, M; O'Sullivan, SS; Williams, DR; Lees, AJ; (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with Dyskinesia. Journal of Parkinson's Disease , 1 (4) pp. 347-357. 10.3233/JPD-2011-11068.

Lindgren, HS; Rylander, D; Iderberg, H; Andersson, M; O'Sullivan, SS; Williams, DR; Lees, AJ; (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. J Parkinsons Dis , 1 (4) pp. 347-357. 10.3233/JPD-2011-11068.

Ling, H; Bhidayasiri, R; (2011) Reduced serum caeruloplasmin levels in non-wilsonian movement disorders. Eur Neurol , 66 (3) pp. 123-127. 10.1159/000330538.

Ling, H; Braschinsky, M; Taba, P; Luus, SM; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of Delayed Diagnosis in 4 Levodopa-Responsive Young-Onset Monogenetic Parkinsonism Patients. MOVEMENT DISORD , 26 (7) 1337 - 1340. 10.1002/mds.23563.

Ling, H; Braschinsky, M; Taba, P; Lüüs, S-M; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients. Movement Disorders

Ling, H; Braschinsky, M; Taba, P; Lüüs, SM; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients. Movement Disorders , 26 (7) pp. 1337-1340. 10.1002/mds.23563.

Ling, H; Massey, L; Lunn, M; Lees, A; (2011) A rare cause of L-Dopa responsive parkinsonism: The answer lies in the eyes. In: MOVEMENT DISORDERS. (pp. S341 - S341).

Ling, H; Polke, JM; Sweeney, MG; Haworth, A; Sandford, CA; Heales, SJR; Wood, NW; (2011) An Intragenic Duplication in Guanosine Triphosphate Cyclohydrolase-1 Gene in a Dopa-Responsive Dystonia Family. MOVEMENT DISORD , 26 (5) 905 - 909. 10.1002/mds.23593.

Ling, H; Polke, JM; Sweeney, MG; Haworth, A; Sandford, CA; Heales, SJR; Wood, NW; (2011) An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family. Movement Disorders , 26 (5) pp. 905-909. 10.1002/mds.23593.

Liu, YT; Murphy, SM; Houlden, H; Reilly, MM; (2011) Neurofilament light chain polypeptide gene (NEFL) mutations in autosomal dominant or sporadic Charcot-Marie-Tooth disease. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17). PERGAMON-ELSEVIER SCIENCE LTD

Loublier, S; Bayot, A; Rak, M; El-Khoury, R; Bénit, P; Rustin, P; (2011) The NDUFB6 subunit of the mitochondrial respiratory chain complex I is required for electron transfer activity: a proof of principle study on stable and controlled RNA interference in human cell lines. Biochem Biophys Res Commun , 414 (2) pp. 367-372. 10.1016/j.bbrc.2011.09.078.

Lubbe, SJ; Pittman, AM; Matijssen, C; Twiss, P; Olver, B; Lloyd, A; Qureshi, M; (2011) Evaluation of germline BMP4 mutation as a cause of colorectal cancer. Hum Mutat , 32 (1) E1928-E1938. 10.1002/humu.21376.

Ludtmann, MH; Boeckeler, K; Williams, RS; (2011) Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder. Semin Cell Dev Biol , 22 (1) pp. 105-113. 10.1016/j.semcdb.2010.11.002.

Léveillé, N; Elkon, R; Davalos, V; Manoharan, V; Hollingworth, D; Oude Vrielink, J; le Sage, C; (2011) Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications , 2 , Article 513. 10.1038/ncomms1519. Green open access
file

Léveillé, N; Elkon, R; Davalos, V; Vrielink, JO; Le Sage, C; Melo, CA; Esteller, M; (2011) Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications , 2 (1) 10.1038/ncomms1519.

M

Machado, P; Castrejon, I; Katchamart, W; Koevoets, R; Kuriya, B; Schoels, M; Silva-Fernández, L; (2011) Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis , 70 (1) pp. 15-24. 10.1136/ard.2010.130625.

Machado, P; Landewé, R; Braun, J; Hermann, KG; Baraliakos, X; Baker, D; Hsu, B; (2011) A stratified model for health outcomes in ankylosing spondylitis. Ann Rheum Dis , 70 (10) pp. 1758-1764. 10.1136/ard.2011.150037.

Machado, P; Landewé, R; Lie, E; Kvien, TK; Braun, J; Baker, D; van der Heijde, D; (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis , 70 (1) pp. 47-53. 10.1136/ard.2010.138594.

Machado, P; Miller, A; Parton, M; Dewar, L; Holton, JL; Dimachkie, M; Herbelir, L; (2011) A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM). In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Machado, P; van der Heijde, D; (2011) How to measure disease activity in axial spondyloarthritis? Curr Opin Rheumatol , 23 (4) pp. 339-345. 10.1097/BOR.0b013e3283470f23.

Machado, PM; Koevoets, R; Bombardier, C; van der Heijde, DM; (2011) The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol Suppl , 87 pp. 31-37. 10.3899/jrheum.101072.

Machado, PM; Landewé, RB; van der Heijde, DM; (2011) Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10. J Rheumatol , 38 (7) pp. 1502-1506. 10.3899/jrheum.110279.

Malik, B; Nirmalananthan, N; Bilsland, LG; La Spada, AR; Hanna, MG; Schiavo, G; Gallo, JM; (2011) Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. HUM MOL GENET , 20 (9) 1776 - 1786. 10.1093/hmg/ddr061.

Marelli, C; van de Leemput, J; Johnson, JO; Tison, F; Thauvin-Robinet, C; Picard, F; Tranchant, C; (2011) SCA15 Due to Large ITPR1 Deletions in a Cohort of 333 White Families With Dominant Ataxia. ARCH NEUROL-CHICAGO , 68 (5) 637 - 643.

Matthews, E; Manzur, AY; Sud, R; Muntoni, F; Hanna, MG; (2011) Stridor as a Neonatal Presentation of Skeletal Muscle Sodium Channelopathy. ARCH NEUROL-CHICAGO , 68 (1) 127 - 129.

Matthews, E; Miller, JAL; Macleod, MR; Ironside, J; Ambler, G; Labrum, R; Sud, R; (2011) SODIUM AND CHLORIDE CHANNELOPATHIES WITH MYOSITIS: COINCIDENCE OR CONNECTION? MUSCLE NERVE , 44 (2) 283 - 288. 10.1002/mus.22120.

Matthews, E; Portaro, S; Ke, Q; Sud, R; Haworth, A; Davis, MB; Griggs, RC; (2011) Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology , 77 (22) pp. 1960-1964. 10.1212/WNL.0b013e31823a0cb6.

Mattsson, N; Andreasson, U; Persson, S; Arai, H; Batish, SD; Bernardini, S; Bocchio-Chiavetto, L; (2011) The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement , 7 (4) 386-395.e6. 10.1016/j.jalz.2011.05.2243.

Mattsson, N; Johansson, P; Hansson, O; Wallin, A; Johansson, JO; Andreasson, U; Andersen, O; (2011) Erratum: Converging pathways of chromogranin and amyloid metabolism in the brain (Journal of Alzheimer's Disease (2010) 20:4 (1039-1048)). Journal of Alzheimer's Disease , 23 (4) 761-. 10.3233/JAD-2010-001435.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Found in translation: a blood-based test for Niemann-Pick type C1. Biomark Med , 5 (2) 201-. 10.2217/bmm.11.10.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Growth factors in Parkinson's disease. Biomark Med , 5 (2) pp. 201-202.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) It is all about clearance. Biomark Med , 5 (2) 202-.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Troponin T: more than acute myocardial infarction. Biomark Med , 5 (2) 203-.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) A new member in the biomarker discovery toolbox. Biomark Med , 5 (2) 202-.

Mattsson, N; Tabatabaei, S; Johansson, P; Hansson, O; Andreasson, U; Månsson, JE; Johansson, JO; (2011) Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility. Neuromolecular Med , 13 (2) pp. 151-159. 10.1007/s12017-011-8147-9.

Mattsson, N; Zetterberg, H; Bianconi, S; Yanjanin, NM; Fu, R; Månsson, JE; Porter, FD; (2011) Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study. Neurology , 76 (4) pp. 366-372. 10.1212/WNL.0b013e318208f4ab.

Mattsson, N; Zetterberg, H; Bianconi, S; Yanjanin, NM; Fu, R; Månsson, JE; Porter, FD; (2011) γ-Secretase-dependent amyloid-β is increased in Niemann-Pick type C: A cross-sectional study. Neurology , 76 (4) pp. 366-372. 10.1212/WNL.0b013e318208f4ab.

McManus, IC; Jonvik, H; Richards, P; Paice, E; (2011) Vocation and avocation: leisure activities correlate with professional engagement, but not burnout, in a cross-sectional survey of UK doctors. BMC Medicine , 9 , Article 100. 10.1186/1741-7015-9-100. Green open access
filefile

Mencacci, NE; Bersano, A; Cinnante, CM; Ciammola, A; Corti, S; Meroni, PL; Silani, V; (2011) Intracerebral haemorrhage, a possible presentation in Churg-Strauss syndrome: Case report and review of the literature. Journal of the Neurological Sciences , 301 (1-2) pp. 107-111. 10.1016/j.jns.2010.10.016.

Meschia, JF; Nalls, M; Matarin, M; Brott, TG; Brown, RD; Hardy, J; Kissela, B; (2011) Siblings With Ischemic Stroke Study Results of a Genome-Wide Scan for Stroke Loci. STROKE , 42 (10) 2726 - U83. 10.1161/STROKEAHA.111.620484.

Meschia, JF; Nalls, MA; Rich, SS; Singleton, A; Hardy, JA; Brott, TG; Brown, RD; (2011) Genome-wide Search for Ischemic Stroke Genes: The Siblings with Ischemic Stroke Study (SWISS). In: STROKE. (pp. E269 - E269). LIPPINCOTT WILLIAMS & WILKINS

Meschia, JF; Singleton, A; Nalls, MA; Rich, SS; Sharma, P; Ferrucci, L; Matarin, M; (2011) Genomic Risk Profiling of Ischemic Stroke: Results of an International Genome-Wide Association Meta-Analysis. PLOS ONE , 6 (9) , Article e23161. 10.1371/journal.pone.0023161. Green open access
file

Miller, A; Ahmed, M; Hanna, MG; Greensmith, L; (2011) The effects of arimoclomol on pathological outcome measures of inclusion body myositis in vitro. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Miller, A; Machado, P; Morrow, JM; Hiscock, A; Dewar, L; Brady, S; Hilton-Jones, D; (2011) The natural history of sporadic inclusion body myositis: development of an electronic database IBMnet. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Morrow, JM; Dewar, EL; Ramdharry, GM; Laura, M; Yousry, TA; Hanna, MG; Reilly, MM; (2011) ISOMETRIC AND ISOKINETIC LOWER LIMB STRENGTH IN CHARCOT-MARIE-TOOTH DISEASE 1A. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S90 - S90). WILEY-BLACKWELL

Morrow, JM; Matthews, E; Rayan, DLR; Amer, I; Fischmann, A; Sinclair, CDJ; Thornton, JS; (2011) Magnetic resonance imaging in the non-dystrophic myotonias. In: NEUROMUSCULAR DISORDERS. (pp. S5 - S5). PERGAMON-ELSEVIER SCIENCE LTD

Morrow, JM; Sinclair, CDJ; Fischmann, A; Thornton, JS; Laura, M; Yousry, TA; Hanna, MG; (2011) QUANTITATIVE MAGNETIC RESONANCE IMAGING OF MUSCLE IN CHARCOT-MARIE-TOOTH DISEASE 1A-A POTENTIAL OUTCOME MEASURE. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S90 - S90). WILEY-BLACKWELL

Moss, ML; Powell, G; Miller, MA; Edwards, L; Qi, B; Sang, QX; De Strooper, B; (2011) ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein. J Biol Chem , 286 (47) pp. 40443-40451. 10.1074/jbc.M111.280495.

Muller, T; Cirak, S; Parton, M; Lunn, M; Hanna, MG; Muntoni, F; (2011) An integrative database for clinical and research studies in neuromuscular diseases. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Mullin, S; Temu, A; Kalluvya, S; Grant, A; Manji, H; (2011) High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania. Trop Med Int Health , 16 (10) pp. 1291-1296. 10.1111/j.1365-3156.2011.02825.x.

Mulugeta, E; Londos, E; Ballard, C; Alves, G; Zetterberg, H; Blennow, K; Skogseth, R; (2011) CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry , 82 (2) pp. 160-164. 10.1136/jnnp.2009.199398.

Mulugeta, E; Londos, E; Hansson, O; Ballard, C; Skogseth, R; Minthon, L; Blennow, K; (2011) Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates. Int J Alzheimers Dis , 2011 495025-. 10.4061/2011/495025.

Murphy, S; Laura, M; Blake, J; Polke, J; Bremner, F; Reilly, MM; (2011) Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a Myelin Protein Zero p.Ile112Thr mutation. Neuromouscular Disorders , 21 223 - 226.

Murphy, S; Polke, J; Manji, H; Blake, J; Sweeney, M; Brandner, S; Reilly, MM; (2011) A novel mutation in the nerve-specific 5′UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth Disease. Journal of the Peripheral Nervous System , 16 65 - 70.

Murphy, S; Reilly, MM; (2011) Amyloid neuropathies. Advances in Clinical Neuroscience and Rehabilitation , 11 (1) 16 - 19.

Murphy, SM; Davidson, GL; Laura, M; Salih, M; Muntoni, F; Lunn, M; Blake, J; (2011) Genetic mutation frequency in patients with hereditary sensory and autonomic neuropathies (HSAN). In: NEUROMUSCULAR DISORDERS. (pp. S17 - S18). PERGAMON-ELSEVIER SCIENCE LTD

Murphy, SM; Davidson, GL; Laura, M; Salih, MAM; Muntoni, F; Lunn, MP; Blake, J; (2011) GENETIC MUTATION FREQUENCY IN PATIENTS WITH HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES (HSAN). In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S93 - S93). WILEY-BLACKWELL

Murphy, SM; Polke, J; Manji, H; Blake, J; Reiniger, L; Sweeney, M; Houlden, H; (2011) A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease. J PERIPHER NERV SYST , 16 (1) 65 - 70. 10.1111/j.1529-8027.2011.00321.x.

Murphy, SM; Siskind, C; Ovens, R; Polke, J; Laura, M; Houlden, H; Murphy, RPJ; (2011) X-inactivation pattern in females with CMTX1. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18). PERGAMON-ELSEVIER SCIENCE LTD

Murphy, SM; Siskind, CE; Ovens, R; Polke, J; Laura, M; Houlden, H; Murphy, RPJ; (2011) X-INACTIVATION PATTERN IN FEMALES WITH CMTX1. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S94 - S94). WILEY-BLACKWELL

Mustafiz, T; Portelius, E; Gustavsson, MK; Hölttä, M; Zetterberg, H; Blennow, K; Nordberg, A; (2011) Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. Neurodegener Dis , 8 (5) pp. 352-363. 10.1159/000323871.

Mörtberg, E; Zetterberg, H; Nordmark, J; Blennow, K; Catry, C; Decraemer, H; Vanmechelen, E; (2011) Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol Scand , 55 (9) pp. 1132-1138. 10.1111/j.1399-6576.2011.02505.x.

Mörtberg, E; Zetterberg, H; Nordmark, J; Blennow, K; Rosengren, L; Rubertsson, S; (2011) S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment. Resuscitation , 82 (1) pp. 26-31. 10.1016/j.resuscitation.2010.10.011.

N

Naj, AC; Jun, G; Beecham, GW; Wang, LS; Vardarajan, BN; Buros, J; Gallins, PJ; (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics , 43 (5) pp. 436-443. 10.1038/ng.801.

Naj, AC; Jun, G; Beecham, GW; Wang, LS; Vardarajan, BN; Buros, J; Gallins, PJ; (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. NAT GENET , 43 (5) 436 - +. 10.1038/ng.801.

Nalls, MA; Plagnol, V; Hernandez, DG; Sharma, M; Sheerin, UM; Saad, M; Simon-Sanchez, J; (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. LANCET , 377 (9766) 641 - 649. 10.1016/S0140-6736(10)62345-8.

Ndosi, M; Tennant, A; Bergsten, U; Kukkurainen, ML; Machado, P; de la Torre-Aboki, J; Vlieland, TP; (2011) Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries. BMC Musculoskelet Disord , 12 110-. 10.1186/1471-2474-12-110.

Nelson, O; Supnet, C; Tolia, A; Horré, K; De Strooper, B; Bezprozvanny, I; (2011) Mutagenesis mapping of the presenilin 1 calcium leak conductance pore. J Biol Chem , 286 (25) pp. 22339-22347. 10.1074/jbc.M111.243063.

Nesbitt, V; Pitceathly, RDS; Rahman, S; Hanna, MG; McFarland, R; Turnbull, DM; (2011) A3243G-more than just MELAS! In: NEUROMUSCULAR DISORDERS. (pp. S21 - S21). PERGAMON-ELSEVIER SCIENCE LTD

Nesbitt, V; Pitceathly, RDS; Rahman, S; Poulton, J; Turnbull, DM; Hanna, MG; McFarland, R; (2011) The MRC Centre for Translational Research in Neuromuscular Disease: Mitochondrial Disease Patient Cohort Study UK. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S30). PERGAMON-ELSEVIER SCIENCE LTD

Nethisinghe, S; Clayton, L; Vermeer, S; Chapple, JP; Reilly, M; Bremner, F; Giunti, P; (2011) Retinal Imaging in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. NEURO-OPHTHALMOLOGY , 35 (4) 197 - 201. 10.3109/01658107.2011.595043.

Nopoulos, PC; Aylward, EH; Ross, CA; Mills, JA; Langbehn, DR; Johnson, HJ; Magnotta, VA; (2011) Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain , 134 (Pt 1) pp. 137-142. 10.1093/brain/awq280.

Noyce, AJ; Bestwick, J; Hawkes, CH; Knowles, CH; Hardy, J; Lees, AJ; Silveira-Moriyama, L; (2011) An algorithm to identify individuals at high-risk of Parkinson's disease in the community. Presented at: UNSPECIFIED.

Noyce, AJ; Bestwick, J; Hawkes, CH; Schrag, A; Knowles, CH; Hardy, J; Lees, AJ; (2011) A pilot study of an algorithm designed to identify Parkinson's disease in the early, non-motor phase. Presented at: UNSPECIFIED.

Noyce, AJ; Gilpin, P; Howard, R; Lees, AJ; Silviera-Moriyama, L; (2011) Severe dysphagia preceding Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S195 - S196).

Nunes, A; Pressey, SNR; Cooper, JD; Soriano, S; (2011) Loss of amyloid precursor protein in a mouse model of Niemann-Pick type C disease exacerbates its phenotype and disrupts tau homeostasis. NEUROBIOL DIS , 42 (3) 349 - 359. 10.1016/j.nbd.2011.01.028.

O

O'Rourke, JJ; Beglinger, LJ; Smith, MM; Mills, J; Moser, DJ; Rowe, KC; Langbehn, DR; (2011) The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance. J Clin Exp Neuropsychol , 33 (5) pp. 567-579. 10.1080/13803395.2010.541228.

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2011) The Effect of Drug Treatment on Neurogenesis in Parkinson's Disease. MOVEMENT DISORD , 26 (1) 45 - 50. 10.1002/23340.

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2011) The effect of drug treatment on neurogenesis in Parkinson's disease. Movement Disorders , 26 (1) pp. 45-50. 10.1002/mds.23340.

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2011) The effect of drug treatment on neurogenesis in Parkinson's disease. Mov Disord , 26 (1) pp. 45-50. 10.1002/mds.23340.

O'Sullivan, SS; Lees, AJ; (2011) Dopamine Dysregulation Syndrome. pp. 202-214. 10.1002/9781444397970.ch19.

O'Sullivan, SS; Loane, CM; Lawrence, AD; Evans, AH; Piccini, P; Lees, AJ; (2011) Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease. J Neurol Neurosurg Psychiatry , 82 (6) pp. 620-622. 10.1136/jnnp.2009.186874.

O'Sullivan, SS; Wu, K; Politis, M; Lawrence, AD; Evans, AH; Bose, SK; Djamshidian, A; (2011) Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain , 134 (4) pp. 969-978. 10.1093/brain/awr003.

O'Sullivan, SS; Wu, K; Politis, M; Lawrence, AD; Evans, AH; Bose, SK; Djamshidian, A; (2011) Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. BRAIN , 134 969 - 978. 10.1093/brain/awr003.

Ohlin, KE; Francardo, V; Lindgren, HS; Sillivan, SE; O'Sullivan, SS; Luksik, AS; Vassoler, FM; (2011) Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain , 134 (Pt 8) pp. 2339-2357. 10.1093/brain/awr165.

Ohrfelt, A; Andreasson, U; Simon, A; Zetterberg, H; Edman, A; Potter, W; Holder, D; (2011) Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease. Dement Geriatr Cogn Dis Extra , 1 (1) pp. 31-42. 10.1159/000323417.

Ohrfelt, A; Zetterberg, H; Andersson, K; Persson, R; Secic, D; Brinkmalm, G; Wallin, A; (2011) Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res , 36 (11) pp. 2029-2042. 10.1007/s11064-011-0527-x.

Olsson, B; Zetterberg, H; Hampel, H; Blennow, K; (2011) Biomarker-based dissection of neurodegenerative diseases. Prog Neurobiol , 95 (4) pp. 520-534. 10.1016/j.pneurobio.2011.04.006.

P

Pandraud, A; Murphy, SM; Laura, M; Reilly, MM; Houlden, H; (2011) Genetic modifying factors for the common form of CMT1A due to the chromosome 17 duplication and other causes of CMT1 in non-CMT1A patients. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18). PERGAMON-ELSEVIER SCIENCE LTD

Parkkinen, L; Neumann, J; O'Sullivan, SS; Holton, JL; Revesz, T; Hardy, J; Lees, AJ; (2011) Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease. MOL GENET METAB , 103 (4) 410 - 412. 10.1016/j.ymgme.2011.04.015.

Parkkinen, L; O'Sullivan, SS; Collins, C; Petrie, A; Holton, JL; Revesz, T; Lees, AJ; (2011) Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease. J Parkinsons Dis , 1 (3) pp. 277-286. 10.3233/JPD-2011-11046.

Parkkinen, L; O'Sullivan, SS; Kuoppamaki, M; Collins, C; Kallis, C; Holton, JL; Williams, DR; (2011) Does levodopa accelerate the pathologic process in Parkinson disease brain? NEUROLOGY , 77 (15) 1420 - 1426. 10.1212/WNL.0b013e318232ab4c.

Parnetti, L; Chiasserini, D; Andreasson, U; Ohlson, M; Hüls, C; Zetterberg, H; Minthon, L; (2011) Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. Acta Neurol Scand , 124 (2) pp. 122-129. 10.1111/j.1600-0404.2010.01435.x.

Patani, R; Hollins, AJ; Wishart, TM; Puddifoot, CA; Alvarez, S; de Lera, AR; Wyllie, DJ; (2011) Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat Commun , 2 214-. 10.1038/ncomms1216.

Peall, KJ; Waite, AJ; Kurian, MA; Hedderly, T; Smith, M; Lin, J-P; King, MD; (2011) Clinical and genetic spectrum of myoclonus dystonia syndrome. Presented at: UNSPECIFIED.

Pearson, JP; Williams, NM; Majounie, E; Waite, A; Stott, J; Newsway, V; Murray, A; (2011) Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J NEUROL , 258 (4) 647 - 655. 10.1007/s00415-010-5815-x.

Petrovic, IN; Martin-Bastida, A; Massey, L; Ling, H; O'sullivan, SS; Williams, DR; Revesz, T; (2011) Creutzfeldt Jacob disease presenting as progressive supranuclear palsy. Presented at: UNSPECIFIED.

Peuralinna, T; Tanskanen, M; Makela, M; Polvikoski, T; Paetau, A; Kalimo, H; Sulkava, R; (2011) APOE and A beta PP Gene Variation in Cortical and Cerebrovascular Amyloid-beta Pathology and Alzheimer's Disease: A Population-Based Analysis. J ALZHEIMERS DIS , 26 (2) 377 - 385. 10.3233/JAD-2011-102049.

Pham, CT; de Silva, R; Haik, S; Verny, M; Sachet, A; Forette, B; Lees, A; (2011) Tau-positive grains are constant in centenarians' hippocampus. NEUROBIOL AGING , 32 (7) 1296 - 1303. 10.1016/j.neurobiolaging.2009.07.009.

Pham, CT; de Silva, R; Haïk, S; Verny, M; Sachet, A; Forette, B; Lees, A; (2011) Tau-positive grains are constant in centenarians' hippocampus. Neurobiology of Aging , 32 (7) pp. 1296-1303. 10.1016/j.neurobiolaging.2009.07.009.

Phukan, J; Albanese, A; Gasser, T; Warner, T; (2011) Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol , 10 (12) pp. 1074-1085. 10.1016/S1474-4422(11)70232-0.

Phukan, J; Warner, TT; (2011) Other Dystonias. In: Oxford Textbook of Movement Disorders. Oxford University Press

Pitceathly, RDS; Fassone, E; Taanman, JW; Sadowski, M; Fratter, C; Mudanohwo, EE; Woodward, CE; (2011) KEARNS-SAYRE SYNDROME CAUSED BY MUTATIONS IN THE NUCLEAR RRM2B GENE. Presented at: UNSPECIFIED.

Pitceathly, RDS; Fassone, E; Taanman, JW; Sadowski, M; Fratter, C; Mudanohwo, EE; Woodward, CE; (2011) Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J MED GENET , 48 (9) 610 - 617. 10.1136/jmg.2010.088328.

Pitceathly, RDS; Fassone, E; Taanman, JW; Sadowski, M; Fratter, C; Mudanohwo, EE; Woodward, CE; (2011) Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. NEUROMUSCULAR DISORDERS , 21 S21 - S21.

Pitceathly, RDS; He, J; Foley, AR; Muntoni, F; Pearson, N; Hanna, MG; (2011) Whole genome analysis in a family with dominant muscle disease. In: NEUROMUSCULAR DISORDERS. (pp. S25 - S25). PERGAMON-ELSEVIER SCIENCE LTD

Plagnol, V; Nalls, MA; Bras, JM; Hernandez, DG; Sharma, M; Sheerin, UM; Saad, M; (2011) A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease. PLoS Genetics , 7 (6) , Article e1002142. 10.1371/journal.pgen.1002142. Green open access
file

Pocock, J; Davenport, C; Jebelli, J; Sevastou, I; Hooper, C; (2011) P53-ACTIVATED PATHWAYS IN MICROGLIA: GOOD OR BAD FOR THE BRAIN? In: GLIA. (pp. S25 - S26). WILEY-BLACKWELL

Polke, JM; Laura, M; Pareyson, D; Taroni, F; Milani, M; Bergamin, G; Gibbons, VS; (2011) Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. NEUROLOGY , 77 (2) 168 - 173. 10.1212/WNL.0b013e3182242d4d.

Pomara, N; Bruno, D; Nierenberg, JJ; Sidtis, JJ; Martiniuk, FT; Mehta, PD; Zetterberg, H; (2011) TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly. Neurochem Res , 36 (6) pp. 1124-1128. 10.1007/s11064-011-0459-5.

Portaro, S; Sweeney, MG; Matthews, E; Sud, R; Musumeci, O; Rodolico, C; Vita, G; (2011) Clinical and molecular genetic studies of a cohort of Italian patients with muscle channelopathies. In: JOURNAL OF NEUROLOGY. (pp. 246 - 246).

Portelius, E; Mattsson, N; Andreasson, U; Blennow, K; Zetterberg, H; (2011) Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment. Curr Pharm Des , 17 (25) pp. 2594-2602.

Portelius, E; Price, E; Brinkmalm, G; Stiteler, M; Olsson, M; Persson, R; Westman-Brinkmalm, A; (2011) A novel pathway for amyloid precursor protein processing. Neurobiol Aging , 32 (6) pp. 1090-1098. 10.1016/j.neurobiolaging.2009.06.002.

Proukakis, C; Moore, D; Labrum, R; Wood, NW; Houlden, H; (2011) Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males. J NEUROL SCI , 306 (1-2) 62 - 65. 10.1016/j.jns.2011.03.043.

R

Rabe, S; Reichwald, J; Ammaturo, D; de Strooper, B; Saftig, P; Neumann, U; Staufenbiel, M; (2011) The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. J Neurochem , 119 (1) pp. 231-239. 10.1111/j.1471-4159.2011.07412.x.

Rajakulendran, S; Paisan-Ruiz, C; Houlden, H; (2011) Thinning of the Corpus Callosum and Cerebellar Atrophy is Correlated with Phenotypic Severity in a Family with Spastic Paraplegia Type 11. J CLIN NEUROL , 7 (2) 102 - 104. 10.3988/jcn.2011.7.2.102. Gold open access

Rajakulendran, S; Parton, M; Holton, JL; Hanna, MG; (2011) CLINICAL AND PATHOLOGICAL HETEROGENEITY IN LATE-ONSET PARTIAL MEROSIN DEFICIENCY. MUSCLE NERVE , 44 (4) 590 - 593. 10.1002/mus.22196.

Rayan, DLR; Haworth, A; Sud, R; Burge, J; Portaro, S; Toscano, A; Hanna, MG; (2011) Large scale chloride channel gene DNA rearrangements are an important cause of recessive myotonia congenita - implications for diagnostic screening. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S15). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Matthews, E; Barreto, G; Tan, SV; Dewar, L; Burge, J; Barohn, R; (2011) Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Matthews, E; Rajakulendran, S; Barreto, G; Tan, SV; Dewar, L; Burge, J; (2011) Genotype-phenotype correlation and longitudinal three year natural history study in the non-dystrophic myotonias in the UK. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Rajakulendran, S; Barreto, G; Tan, SV; Dewar, L; Griggs, RC; Hanna, MG; (2011) Genotype-phenotype correlation and longitudinal study of Andersen-Tawil Syndrome in the UK. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Renton, AE; Majounie, E; Waite, A; Simon-Sanchez, J; Rollinson, S; Gibbs, JR; Schymick, JC; (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. NEURON , 72 (2) 257 - 268. 10.1016/j.neuron.2011.09.010.

Revesz, T; Rostagno, A; Plant, G; Lashley, T; Frangione, B; Ghiso, J; Holton, JL; (2011) Inherited Amyloidoses and Neurodegeneration: Familial British Dementia and Familial Danish Dementia. pp. 439-445. 10.1002/9781444341256.ch46.

Revesz, T; Schott, JM; Reiniger, L; Thom, M; Holton, JL; Grieve, J; Brandner, S; (2011) Brain biopsy in dementia: clinical indications and neuropathological diagnostic approach. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 10 - 10). WILEY-BLACKWELL PUBLISHING, INC

Reynolds, EH; Healy, DG; Lees, AJ; (2011) A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson. Mov Disord , 26 (14) pp. 2453-2459. 10.1002/mds.23536.

Riviere, JB; Ramalingam, S; Lavastre, V; Shekarabi, M; Holbert, S; Lafontaine, J; Srour, M; (2011) KIF1A, an Axonal Transporter of Synaptic Vesicles, Is Mutated in Hereditary Sensory and Autonomic Neuropathy Type 2. AM J HUM GENET , 89 (2) 219 - 230. 10.1016/j.ajhg.2011.06.013.

Rodriguez-Violante, M; Lees, AJ; Cervantes-Arriaga, A; Corona, T; Silveira-Moriyama, L; (2011) Use of Smell Test Identification in Parkinson's Disease in Mexico: A Matched Case-Control Study. MOVEMENT DISORD , 26 (1) 173 - 176. 10.1002/mds.23354.

Rodríguez-Violante, M; Lees, AJ; Cervantes-Arriaga, A; Corona, T; Silveira-Moriyama, L; (2011) Use of smell test identification in Parkinson's disease in Mexico: A matched case-control study. Movement Disorders , 26 (1) pp. 173-176. 10.1002/mds.23354.

Rohrer, JD; Lashley, T; Holton, J; Revesz, T; Urwin, H; Isaacs, AM; Fox, NC; (2011) The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. J NEUROL NEUROSUR PS , 82 (12) 1405 - 1407. 10.1136/jnnp.2010.214437.

Rohrer, JD; Lashley, T; Schott, JM; Warren, JE; Mead, S; Isaacs, AM; Beck, J; (2011) Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. BRAIN , 134 2565 - 2581. 10.1093/brain/awr198. Gold open access

Rohrer, JD; Paviour, D; Vandrovcova, J; Hodges, J; de Silva, R; Rossor, MN; (2011) Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy Syndrome. NEURODEGENER DIS , 8 (3) 149 - 152. 10.1159/000319454.

Rollinson, S; Mead, S; Snowden, J; Richardson, A; Rohrer, J; Halliwell, N; Usher, S; (2011) Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. NEUROBIOL AGING , 32 (4) , Article 758.e1. 10.1016/j.neurobiolaging.2010.12.005.

Rolstad, S; Berg, AI; Bjerke, M; Blennow, K; Johansson, B; Zetterberg, H; Wallin, A; (2011) Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment. J Alzheimers Dis , 26 (1) pp. 135-142. 10.3233/JAD-2011-110038.

Ross, OA; Soto-Ortolaza, AI; Verbeeck, C; Rich, SS; Singleton, A; Hardy, JA; Brott, TG; (2011) Results of NOTCH3 Sequencing in Siblings with Ischemic Stroke Study Probands. In: STROKE. (pp. E269 - E269). LIPPINCOTT WILLIAMS & WILKINS

Rossor, A; Houlden, H; Reilly, MM; (2011) A clinical study of the hereditary neuropathies due to mutations in the small heat shock proteins. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S19). PERGAMON-ELSEVIER SCIENCE LTD

Rosén, C; Mattsson, N; Johansson, PM; Andreasson, U; Wallin, A; Hansson, O; Johansson, JO; (2011) Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases. Front Aging Neurosci , 3 1-. 10.3389/fnagi.2011.00001.

Rott, R; Szargel, R; Haskin, J; Bandopadhyay, R; Lees, AJ; Shani, V; Engelender, S; (2011) α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A , 108 (46) pp. 18666-18671. 10.1073/pnas.1105725108.

Rudolph, T; Sjölander, A; Palmér, MS; Minthon, L; Wallin, A; Andreasen, N; Tasa, G; (2011) Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts. Ophthalmic Genet , 32 (2) pp. 75-79. 10.3109/13816810.2010.544360.

Russo, M; Laura, M; Polke, JM; Davis, MB; Blake, J; Brandner, S; Hughes, RAC; (2011) Variable phenotypes are associated with PMP22 missense mutations. NEUROMUSCULAR DISORD , 21 (2) 106 - 114. 10.1016/j.nmd.2010.11.011.

S

Sagare, AP; Deane, R; Zetterberg, H; Wallin, A; Blennow, K; Zlokovic, BV; (2011) Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease. J Alzheimers Dis , 24 (1) pp. 25-34. 10.3233/JAD-2010-101248.

Sailer, A; Scholz, SW; Gibbs, JR; Johnson, JO; Wood, NW; Hernandez, D; Hardy, J; (2011) EXOME SEQUENCING AS A RAPID AND COST EFFICIENT DIAGNOSTIC METHOD IN NEUROGENETIC DISORDERS. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 552 - 552). WILEY-BLACKWELL

Sannerud, R; Declerck, I; Peric, A; Raemaekers, T; Menendez, G; Zhou, L; Veerle, B; (2011) ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc Natl Acad Sci U S A , 108 (34) E559-E568. 10.1073/pnas.1100745108.

Sanotsky, Y; Selikhova, M; Fedorishin, L; Stanetska, H; Komnatska, I; Tripoliti, E; Lees, AJ; (2011) Speech disorder in ephedrone induced parkinsonism with dystonia. In: MOVEMENT DISORDERS. (pp. S46 - S46).

Sawcer, S; Hellenthal, G; Pirinen, M; Spencer, CCA; Patsopoulos, NA; Moutsianas, L; Dilthey, A; (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. NATURE , 476 (7359) 214 - 219. 10.1038/nature10251.

Schmitz-Hubsch, T; Coudert, M; du Montcel, ST; Giunti, P; Labrum, R; Durr, A; Ribai, P; (2011) Depression Comorbidity in Spinocerebellar Ataxia. MOVEMENT DISORD , 26 (5) 870 - 876. 10.1002/mds.23698.

Schneider, P; Buerger, K; Teipel, S; Uspenskaya, O; Hartmann, O; Hansson, O; Minthon, L; (2011) Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment. Biol Psychiatry , 70 (2) pp. 145-151. 10.1016/j.biopsych.2011.01.036.

Schrag, A; Hobart, J; Selai, C; Quinn, N; Lees, AJ; Litvan, I; Lang, A; (2011) Measuring quality of life in progressive supranuclear palsy: The PSP-QoL. pp. 52-59. 10.1017/CBO9780511975363.006.

Scoto, M; Cirak, S; Mein, R; Feng, L; Manzur, AY; Robb, S; Childs, AM; (2011) SEPN1 related myopathies: Clinical course in a large cohort of patients. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S26). PERGAMON-ELSEVIER SCIENCE LTD

Scoto, M; Cirak, S; Mein, R; Feng, L; Manzur, AY; Robb, S; Childs, AM; (2011) SEPN1-related myopathies Clinical course in a large cohort of patients. NEUROLOGY , 76 (24) pp. 2073-2078.

Setó-Salvia, N; Clarimón, J; Pagonabarraga, J; Pascual-Sedano, B; Campolongo, A; Combarros, O; Mateo, JI; (2011) Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol , 68 (3) pp. 359-364. 10.1001/archneurol.2011.17.

Sharma, S; Bandopadhyay, R; Lashley, T; Renton, AEM; Kingsbury, AE; Kumaran, R; Kallis, C; (2011) LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study. NEUROPATH APPL NEURO , 37 (7) 777 - 790. 10.1111/j.1365-2990.2011.01187.x.

Sibley, CR; Wood, MJ; (2011) Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's disease. PLoS One , 6 (10) , Article e26194. 10.1371/journal.pone.0026194. Green open access
file

Sibley, CR; Wood, MJ; (2011) The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy. J Mol Med (Berl) , 89 (11) pp. 1065-1077. 10.1007/s00109-011-0781-z.

Silveira-Moriyama, L; Lees, AJ; (2011) Up with the lark A panoptic view of Parkinson disease. NEUROLOGY , 77 (4) 310 - 311.

Silveira-Moriyama, L; Yip, HLK; Kearney, S; Revesz, T; Lees, A; (2011) Parkinsonism without Pathological Abnormality. In: NEUROLOGY. (pp. A40 - A41). LIPPINCOTT WILLIAMS & WILKINS

Sims, R; Dwyer, S; Harold, D; Gerrish, A; Hollingworth, P; Chapman, J; Jones, N; (2011) No Evidence that Extended Tracts of Homozygosity are Associated with Alzheimer's Disease. AM J MED GENET B , 156B (7) 764 - 771. 10.1002/ajmg.b.31216.

Sinclair, CDJ; Miranda, MA; Cowley, P; Morrow, JM; Davagnanam, I; Mehta, H; Hanna, MG; (2011) MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathies. J NEUROL NEUROSUR PS , 82 (11) 1283 - 1286. 10.1136/jnnp.2010.211334.

Sinclair, CDJ; Morrow, JM; Fischmann, A; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; (2011) MRI shows increased tibial nerve size in CMT1A. In: NEUROMUSCULAR DISORDERS. (pp. S28 - S28). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Fischmann, A; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; (2011) Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A. In: NEUROMUSCULAR DISORDERS. (pp. S5 - S5). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; Thornton, JS; (2011) Improved magnetization transfer MRI of skeletal muscle in myopathy and neuropathy. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Singleton, A; Hardy, J; (2011) A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Hum Mol Genet , 20 (R2) R158-R162. 10.1093/hmg/ddr358.

Siskind, C; Murphy, S; Ovens, R; Polke, J; Reilly, MM; Shy, ME; (2011) Phenotype expression in women with CMT1X. Journal of the Peripheral Nervous System , 16 (2) 102 - 107.

Skoff, SM; Hendricks, RJ; Sinclair, CDJ; Hudson, JJ; Segal, DM; Sauer, BE; Hinds, EA; (2011) Diffusion, thermalization, and optical pumping of YbF molecules in a cold buffer-gas cell. PHYS REV A , 83 (2) , Article 023418. 10.1103/PhysRevA.83.023418.

Song, C; Kanai, R; Fleming, SM; Weil, RS; Schwarzkopf, DS; Rees, G; (2011) Relating inter-individual differences in metacognitive performance on different perceptual tasks. Conscious Cogn , 20 (4) pp. 1787-1792. 10.1016/j.concog.2010.12.011.

Spencer, CCA; Plagnol, V; Strange, A; Gardner, M; Paisan-Ruiz, C; Band, G; Barker, RA; (2011) Dissection of the genetics of Parkinson's disease identifies an additional association 5 ' of SNCA and multiple associated haplotypes at 17q21. HUM MOL GENET , 20 (2) 345 - 353. 10.1093/hmg/ddq469.

Spencer, CCA; Plagnol, V; Strange, A; Gardner, M; Paisan-Ruiz, C; Band, G; Barker, RA; (2011) Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Human Molecular Genetics , 20 (2) pp. 345-353. 10.1093/hmg/ddq469.

Spillane, JE; Hanna, MG; Kullmann, DM; (2011) Synaptic mechanisms in P/Qdeficient neuromuscular junctions. In: NEUROMUSCULAR DISORDERS. (pp. S15 - S15). PERGAMON-ELSEVIER SCIENCE LTD

Statland, J; Wang, Y; Bundy, B; Trivedi, J; Herbelin, L; Pandya, S; Martens, W; (2011) A Quantitative Measure of Handgrip Myotonia in Patients with Non-Dystrophic Myotonia. In: NEUROLOGY. (pp. A531 - A531).

Statland, JM; Wang, Y; Richesson, R; Bundy, B; Herbelin, L; Gomes, J; Trivedi, J; (2011) AN INTERACTIVE VOICE RESPONSE DIARY FOR PATIENTS WITH NON-DYSTROPHIC MYOTONIA. MUSCLE NERVE , 44 (1) 30 - 35. 10.1002/mus.22007.

Sultan, SM; Allen, E; Cooper, RG; Agarwal, S; Kiely, P; Oddis, CV; Vencovsky, J; (2011) Interrater reliability and aspects of validity of the myositis damage index. ANN RHEUM DIS , 70 (7) 1272 - 1276. 10.1136/ard.2010.142117.

T

Taccioli, C; Maselli, V; Tegnér, J; Gomez-Cabrero, D; Altobelli, G; Emmett, W; Lescai, F; (2011) ParkDB: a Parkinson's disease gene expression database. Database , 2011 (May 20) , Article bar007. 10.1093/database/bar007. Green open access
file

Tan, CD; Hanna, M; Rodriguez, ER; (2011) Immunohistochemical Evaluation of Amyloidosis in Endomyocardial Biopsies. In: LABORATORY INVESTIGATION. (pp. 79A - 79A).

Tan, CL; Kwok, JC; Patani, R; Ffrench-Constant, C; Chandran, S; Fawcett, JW; (2011) Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci , 31 (17) pp. 6289-6295. 10.1523/JNEUROSCI.0008-11.2011.

Tan, SV; Matthews, E; Barber, M; Burge, JA; Rajakulendran, S; Fialho, D; Sud, R; (2011) Refined Exercise Testing Can Aid DNA-Based Diagnosis in Muscle Channelopathies. ANN NEUROL , 69 (2) 328 - 340. 10.1002/ana.22238. Gold open access

Thathiah, A; De Strooper, B; (2011) The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat Rev Neurosci , 12 (2) pp. 73-87. 10.1038/nrn2977.

Thimiri Govinda Raj, DB; Ghesquière, B; Tharkeshwar, AK; Coen, K; Derua, R; Vanderschaeghe, D; Rysman, E; (2011) A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes. Mol Syst Biol , 7 541-. 10.1038/msb.2011.74.

Tollervey, JR; Curk, T; Rogelj, B; Briese, M; Cereda, M; Kayikci, M; König, J; (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci , 14 (4) pp. 452-458. 10.1038/nn.2778.

Tollervey, JR; Wang, Z; Hortobágyi, T; Witten, JT; Zarnack, K; Kayikci, M; Clark, TA;